Kimberly-Clark Corporation (KMB) - Stock Report

Management's 2026 guide is the near-term proof frame: organic sales are expected in line with to ahead of roughly 2.5% weighted-average category and country growth, adjusted operating profit is expected to rise mid-to-high single digits in constant currency, adjusted EPS from continuing operations is expected to rise double digits in constant currency, and adjusted EPS attributable to Kimberly-Clark is expected to be flat in constant currency.

The latest reported quarter is fiscal Q1 2026, released on 28 April 2026. Continuing net sales were $4.163 billion, up 2.7%, with 2.5% organic growth; volume-plus-mix added 3.0%, net price subtracted 0.5%, the U.S. private-label diaper exit subtracted 1.8%, and currency added 2.0%. Reported operating profit was $753 million and adjusted operating profit was $732 million, up 3.7%; reported diluted EPS from continuing operations was $1.70 and adjusted diluted EPS from continuing operations was $1.60, down 1.2%. Reported EPS attributable to Kimberly-Clark was $2.00 versus adjusted EPS attributable of $1.97, because a $120 million insurance recovery more than offset $99 million of Transformation and Kenvue-related charges. For the quarter, OCF less capex was $321 million against $418 million of dividends, so the headline cash-coverage point is a timing signal, not a full-year run-rate.

The Q1 charge bridge is noisy but explainable: 2024 Transformation Initiative gross charges were $51 million and net charges attributable to Kimberly-Clark were $31 million; Kenvue acquisition charges were $48 million; the insurance recovery was a $120 million benefit; and IFP separation costs were $32 million pre-tax, or $24 million net after an $8 million tax effect.

The key macro issue is not household-products demand in isolation, but whether pulp, polymer, energy and retailer pressure pass through gross margin into post-capex cash coverage: if Kimberly-Clark rebuilds margin and proves Kenvue cash conversion, the reset can support per-share value; if not, stable volumes still leave dividend coverage and valuation stretched.

Kimberly-Clark sells essential personal care and tissue products under brands including Huggies, Pull-Ups, Kleenex, Scott, Cottonelle, Kotex, Depend and Poise. This is not a pure brand-royalty model: the company converts fluff pulp, cellulose fiber, polypropylene, superabsorbent materials and other synthetics into disposable and frequently purchased products. The brands create demand and shelf access; manufacturing, procurement and productivity decide the margin.

After the International Family Care and Professional transaction with Suzano, continuing operations are North America and International Personal Care. North America is the mature cash engine and customer-concentration test; Walmart represented 16% of 2025 continuing net sales, primarily in North America. International Personal Care is the faster mix and volume engine, with more currency and country exposure. The IFP business is now discontinued operations; Suzano is expected to buy a 51% joint-venture interest for about $1.7 billion, while Kimberly-Clark retains 49%.

Management is trying to tilt the company toward higher-return personal care, proprietary innovation and supply-chain productivity under Powering Care. The pending Kenvue deal is the larger capital-allocation event: each Kenvue share is to receive 0.14625 Kimberly-Clark shares plus $3.50 in cash, implying roughly 280 million new Kimberly-Clark shares and about $6.7 billion of cash consideration before closing adjustments. Until acquired cash conversion is visible, Kenvue is a proof item, not a valuation free option.